UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 17, 2018
Accession Number:
0001171843-18-006965
Submission Type:
POS AM
CIK:
0001444192
Company Name:
Acasti Pharma Inc.
File Number:
333-220755